SYNAPTICURE
Live / Registered — Registered (as of 12 Apr 2022)
What this means for you
Registered since 12 Apr 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90188939
- Registration number
- 6702483
- Mark type
- Stylized text
- Filed
- 17 Sept 2020
- Published for opposition
- 13 Jul 2021
- Registered
- 12 Apr 2022
- Attorney of record
- Elizabeth Oliner
Goods and services
- Class 035 — Advertising and business services: Referrals in the field of neurodegenerative medicine, namely, doctor and clinical trial referral services to patients with neurodegenerative diseases
- Class 042 — Scientific and technological services: Providing medical research information in the nature of sharing data sets containing patient data for neurodegenerative-disease research purposes
- Class 044 — Medical, beauty and agricultural services: Providing telehealth in the nature of telemedicine services and health-care-consulting in the field of neurodegenerative disease; maintaining patient medical records electronically; genetic testing for medical purposes, namely, providing disease and genetic analysis services to patients by screening therapies best suited for individual patients through use of proprietary models
Owner
- SynaptiCure, Inc., Chicago, IL, US
- SynaptiCure, Inc., Chicago, IL, US
- SynaptiCure, Inc., Chicago, IL, US
Prosecution history
- 12 Apr 2022 — REGISTERED-PRINCIPAL REGISTER
- 10 Mar 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Mar 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Mar 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Feb 2022 — USE AMENDMENT FILED
- 02 Mar 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Feb 2022 — TEAS STATEMENT OF USE RECEIVED
- 07 Sept 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Jul 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jul 2021 — PUBLISHED FOR OPPOSITION
- 23 Jun 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Jun 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Jun 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Jun 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Jun 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED